New York State Psychiatric Institute
465
10
15
334
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
15.9%
74 terminated/withdrawn out of 465 trials
81.9%
-4.6% vs industry average
21%
97 trials in Phase 3/4
68%
226 of 334 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (465)
Dopamine D3 Receptor Occupancy in Bipolar Depression
Role: lead
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
Role: lead
Glutamatergic Mechanisms: Aim2
Role: lead
Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
Role: lead
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Role: lead
Repeated Administration of Cannabis Varying in THC and CBD
Role: lead
Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans
Role: lead
A Multimodal Imaging Study of Dopamine in Early Psychosis
Role: lead
Tailoring Overdose Education for Black Churches
Role: lead
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Role: lead
Valacyclovir for Mild Cognitive Impairment
Role: lead
Shared Decision Making for Antipsychotic Medications
Role: lead
Relapse Prevention and Changing Habits in Anorexia Nervosa
Role: lead
Facilitating Opioid Care Connections
Role: lead
Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
Role: lead
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts
Role: lead
The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder
Role: lead
Helping Adults With Obsessive-Compulsive Disorder Succeed at Work
Role: lead
Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons
Role: collaborator
Effects of rTMS on Food Choice in Anorexia Nervosa
Role: lead